Enhanced Transmembrane Delivery of Chemotherapeutic Agent Doxorubicin by Carbon Nanotubes Under Plasma Synergy: Molecular Dynamics Insights
Biomolecules · 03.05.2026 · 16 (5) · 679
DOI: 10.3390/biom16050679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 03.05.2026. Verfasst von Roujia Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical Engineering, Shandong University, Jinan 250061, China. Hauptthemen laut MEDLINE: Doxorubicin, Nanotubes, Carbon, Molecular Dynamics Simulation, Plasma Gases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin (DOX) is widely used in clinical chemotherapy, but its susceptibility to oxidation during the combined treatment with cold atmospheric plasma (CAP) raises concerns regarding its therapeutic efficacy. To improve drug stability and targeted delivery efficiency, this study employed classical molecular dynamics simulations to systematically investigate the mechanisms by which CAP-generated active particles and electric fields influence DOX encapsulation by carbon nanotubes (CNTs) and their transmembrane transport. Within a specific range of active particle concentrations, DOX aggregation is suppressed, enabling its spontaneous entry into CNTs for encapsulation. The CAP-induced electric field further promotes the directional migration of DOX, and once a threshold field strength is reached, the encapsulation efficiency is significantly enhanced. Moreover, an appropriate concentration of active particles can lower this threshold, enabling high encapsulation efficiency at electric field strengths as low as 0.3 V/nm. The introduction of CNTs can reduce the exposure of DOX to active particles, thereby effectively protecting it from CAP-induced oxidation. Regarding transmembrane transport, CAP-induced lipid oxidation decreases membrane structural stability, facilitating the intracellular internalization of CNTs and promoting the release of DOX within target cells. Furthermore, under the combined effects of oxidation and electric fields, the pulling force required for CNT transmembrane transport further decreases, the size of transmembrane pores increases, and the transmembrane delivery of DOX is enhanced. These results demonstrate that, under plasma synergy, CNTs exhibit significant potential in enhancing the targeted delivery of chemotherapeutic agents. This work provides important theoretical support for the application of plasma in targeted cancer therapy and offers new insights for the design of precision cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Electrical Engineering, Shandong University, Jinan 250061, China.
ORCID-Profile: Tong Zhao, Ying Sun, Yuantao Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lin, R., Zhao, T., Niu, Y., Wang, X., Sun, Y., & Zhang, Y. (2026). Enhanced Transmembrane Delivery of Chemotherapeutic Agent Doxorubicin by Carbon Nanotubes Under Plasma Synergy: Molecular Dynamics Insights. Biomolecules, 16(5), 679. https://doi.org/10.3390/biom16050679
Vancouver
Lin R, Zhao T, Niu Y, Wang X, Sun Y, Zhang Y. Enhanced Transmembrane Delivery of Chemotherapeutic Agent Doxorubicin by Carbon Nanotubes Under Plasma Synergy: Molecular Dynamics Insights. Biomolecules. 2026;16(5):679. doi:10.3390/biom16050679
BibTeX
@article{Lin2026,
author = {Lin, Roujia and Zhao, Tong and Niu, Yanxiong and Wang, Xiaolong and Sun, Ying and Zhang, Yuantao},
title = {Enhanced Transmembrane Delivery of Chemotherapeutic Agent Doxorubicin by Carbon Nanotubes Under Plasma Synergy: Molecular Dynamics Insights},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {679},
doi = {10.3390/biom16050679}
}
EUVIMED